Raymond James Financial Services Advisors’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-4,061
Closed -$293K 2788
2019
Q4
$293K Sell
4,061
-112
-3% -$13.8K ﹤0.01% 2333
2019
Q3
$585K Sell
4,173
-18
-0.4% -$3.01K ﹤0.01% 1805
2019
Q2
$767K Sell
4,191
-433
-9% -$73.9K ﹤0.01% 1654
2019
Q1
$735K Sell
4,624
-325
-7% -$47.1K ﹤0.01% 1642
2018
Q4
$474K Sell
4,949
-306
-6% -$35K ﹤0.01% 1707
2018
Q3
$742K Buy
5,255
+481
+10% +$74.2K ﹤0.01% 1657
2018
Q2
$747K Buy
4,774
+2,308
+94% +$362K ﹤0.01% 1607
2018
Q1
$397K Buy
2,466
+1,025
+71% +$174K ﹤0.01% 1857
2017
Q4
$237K Sell
1,441
-6,594
-82% -$639K ﹤0.01% 2153
2017
Q3
$501K Sell
8,035
-647
-7% -$50.8K ﹤0.01% 1715
2017
Q2
$691K Buy
8,682
+2,525
+41% +$183K ﹤0.01% 1492
2017
Q1
$438K Sell
6,157
-1,405
-19% -$82.3K ﹤0.01% 1662
2016
Q4
$386K Buy
+7,562
New +$356K ﹤0.01% 1672

Other funds holding SAGE